Please read this page carefully. It governs your use of this website.
Last updated: June 2026
These Terms of Use ("Terms") govern your access to and use of immunomet.com (the "Site"), operated by ImmunoMet Therapeutics, Inc. By using the Site, you agree to these Terms.
The Site provides general information about ImmunoMet and its research and development programmes. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Nothing on the Site is an offer to sell, or a solicitation of an offer to buy, any security, nor is it investment advice. Forward-looking statements involve risks and uncertainties, and actual results may differ.
Lixumistat (IM156) is an investigational compound. It has not been approved by the U.S. Food and Drug Administration or any other regulatory authority, and its safety and efficacy have not been established. Clinical data described on the Site are interim, may be based on a limited number of patients, and are subject to change as studies progress. Past or interim results are not necessarily predictive of future results.
The Site may contain forward-looking statements about ImmunoMet's strategy, pipeline, clinical development plans, and prospects. These statements reflect current expectations and involve known and unknown risks and uncertainties, including those relating to drug development, clinical-trial outcomes, regulatory review, and financing. Actual results may differ materially from those expressed or implied. ImmunoMet undertakes no obligation to update any forward-looking statement except as required by law.
The content, design, logos, and trademarks on the Site are owned by ImmunoMet or its licensors and are protected by intellectual-property laws. You may view and download materials for personal, non-commercial use only, and may not reproduce, distribute, or modify them without our prior written permission.
The Site may link to third-party websites. We are not responsible for the content or practices of those sites, and links do not imply endorsement.
The Site is provided on an "as is" and "as available" basis without warranties of any kind. To the fullest extent permitted by law, ImmunoMet is not liable for any damages arising from your use of, or inability to use, the Site.
These Terms are governed by the laws of the State of Texas, USA, without regard to its conflict-of-law principles.
We may revise these Terms from time to time. Continued use of the Site after changes take effect constitutes acceptance of the revised Terms.
Questions about these Terms can be sent through the contact page.
